196 related articles for article (PubMed ID: 16352338)
21. Long-term outcome and short-term survival of patients with systemic lupus erythematosus after bacteraemia episodes: 6-yr follow-up.
Chen MJ; Tseng HM; Huang YL; Hsu WN; Yeh KW; Wu TL; See LC; Huang JL
Rheumatology (Oxford); 2008 Sep; 47(9):1352-7. PubMed ID: 18565988
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for recurrence and death after bacteraemia: a population-based study.
Jensen US; Knudsen JD; Wehberg S; Gregson DB; Laupland KB
Clin Microbiol Infect; 2011 Aug; 17(8):1148-54. PubMed ID: 21714830
[TBL] [Abstract][Full Text] [Related]
23. Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis.
Cherif H; Kronvall G; Björkholm M; Kalin M
Hematol J; 2003; 4(6):420-6. PubMed ID: 14671614
[TBL] [Abstract][Full Text] [Related]
24. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies.
Trecarichi EM; Tumbarello M; Spanu T; Caira M; Fianchi L; Chiusolo P; Fadda G; Leone G; Cauda R; Pagano L
J Infect; 2009 Apr; 58(4):299-307. PubMed ID: 19272650
[TBL] [Abstract][Full Text] [Related]
25. Multiple myeloma following an episode of community-acquired pneumococcal bacteraemia or meningitis.
Gregersen H; Pedersen G; Svendsen N; Thulstrup AM; Sørensen HT; Schønheyder HC
APMIS; 2001 Nov; 109(11):797-800. PubMed ID: 11900061
[TBL] [Abstract][Full Text] [Related]
26. Obesity and smoking are factors associated with poor prognosis in patients with bacteraemia.
Huttunen R; Laine J; Lumio J; Vuento R; Syrjänen J
BMC Infect Dis; 2007 Mar; 7():13. PubMed ID: 17349033
[TBL] [Abstract][Full Text] [Related]
27. [Two thousands seven hundred and thirty nine episodes of bacteremia in the county of Northern Jutland 1996-1998. Presentation of a regional clinical database].
Schønheyder HC
Ugeskr Laeger; 2000 May; 162(20):2886-91. PubMed ID: 10860428
[TBL] [Abstract][Full Text] [Related]
28. Bacteraemia in febrile neutropenic cancer patients.
Klastersky J; Ameye L; Maertens J; Georgala A; Muanza F; Aoun M; Ferrant A; Rapoport B; Rolston K; Paesmans M
Int J Antimicrob Agents; 2007 Nov; 30 Suppl 1():S51-9. PubMed ID: 17689933
[TBL] [Abstract][Full Text] [Related]
29. Bacteraemia in the elderly: predictors of outcome in an urban teaching hospital.
Greenberg BM; Atmar RL; Stager CE; Greenberg SB
J Infect; 2005 May; 50(4):288-95. PubMed ID: 15845426
[TBL] [Abstract][Full Text] [Related]
30. Bacteraemia among severely malnourished children infected and uninfected with the human immunodeficiency virus-1 in Kampala, Uganda.
Bachou H; Tylleskär T; Kaddu-Mulindwa DH; Tumwine JK
BMC Infect Dis; 2006 Nov; 6():160. PubMed ID: 17090299
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for mortality of nosocomial bacteraemia in intensive care units.
Cağatay AA; Ozcan PE; Gulec L; Ince N; Tugrul S; Ozsut H; Cakar N; Esen F; Eraksoy H; Calangu S
Med Princ Pract; 2007; 16(3):187-92. PubMed ID: 17409752
[TBL] [Abstract][Full Text] [Related]
32. Tunnelled haemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality.
Mokrzycki MH; Zhang M; Cohen H; Golestaneh L; Laut JM; Rosenberg SO
Nephrol Dial Transplant; 2006 Apr; 21(4):1024-31. PubMed ID: 16449293
[TBL] [Abstract][Full Text] [Related]
33. Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis.
Thulstrup AM; Sørensen HT; Schønheyder HC; Møller JK; Tage-Jensen U
Clin Infect Dis; 2000 Dec; 31(6):1357-61. PubMed ID: 11096002
[TBL] [Abstract][Full Text] [Related]
34. Outbreak of Ralstonia pickettii bacteraemia in patients with haematological malignancies and haematopoietic stem cell transplant recipients.
Mikulska M; Durando P; Pia Molinari M; Alberti M; Del Bono V; Dominietto A; Raiola AM; Van Lint MT; Bregante S; Orengo G; Bacigalupo A; Viscoli C
J Hosp Infect; 2009 Jun; 72(2):187-8. PubMed ID: 19376610
[No Abstract] [Full Text] [Related]
35. The spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patients.
Rolston KV; Yadegarynia D; Kontoyiannis DP; Raad II; Ho DH
Int J Infect Dis; 2006 May; 10(3):223-30. PubMed ID: 16439177
[TBL] [Abstract][Full Text] [Related]
36. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy.
Fortún J; Grill F; Martín-Dávila P; Blázquez J; Tato M; Sánchez-Corral J; García-San Miguel L; Moreno S
J Antimicrob Chemother; 2006 Oct; 58(4):816-21. PubMed ID: 16899468
[TBL] [Abstract][Full Text] [Related]
37. 30-day mortality after peptic ulcer perforation among users of newer selective COX-2 inhibitors and traditional NSAIDs: a population-based study.
Thomsen RW; Riis A; Munk EM; Nørgaard M; Christensen S; Sørensen HT
Am J Gastroenterol; 2006 Dec; 101(12):2704-10. PubMed ID: 17026569
[TBL] [Abstract][Full Text] [Related]
38. Moxifloxacin prophylaxis in neutropenic patients.
von Baum H; Sigge A; Bommer M; Kern WV; Marre R; Döhner H; Kern P; Reuter S
J Antimicrob Chemother; 2006 Oct; 58(4):891-4. PubMed ID: 16880172
[TBL] [Abstract][Full Text] [Related]
39. Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study.
Fernandez-Hidalgo N; Almirante B; Calleja R; Ruiz I; Planes AM; Rodriguez D; Pigrau C; Pahissa A
J Antimicrob Chemother; 2006 Jun; 57(6):1172-80. PubMed ID: 16597634
[TBL] [Abstract][Full Text] [Related]
40. Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy.
Falagas ME; Kasiakou SK; Rafailidis PI; Zouglakis G; Morfou P
J Antimicrob Chemother; 2006 Jun; 57(6):1251-4. PubMed ID: 16627593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
